Abstract
Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.
Funding Information
  • Centers for Disease Control and Prevention

This publication has 20 references indexed in Scilit: